期刊文献+

匹多莫德口服液和红霉素治疗支原体肺炎94例 被引量:6

下载PDF
导出
摘要 目的观察匹多莫德口服液治疗小儿肺炎支原体肺炎的临床疗效。方法回顾性分析医院收治的94例肺炎支原体肺炎患儿的临床资料,其中对照组46例给予红霉素抗感染治疗,观察组48例加用匹多莫德口服液治疗。结果观察组发热时间、肺部罗音消失时间及住院时间均较对照组明显缩短,差异有显著性(P<0.01);观察组的临床疗效明显高于对照组(P<0.05)。结论红霉素联合匹多莫德口服液治疗肺炎支原体肺炎,临床疗效满意,联合用药具有优越性。
作者 黄文渊
出处 《中国药业》 CAS 2013年第7期92-93,共2页 China Pharmaceuticals
  • 相关文献

参考文献10

  • 1中华医学会.临床诊疗指南·小儿内科分册[M].北京:人民卫生出版社,2005:50
  • 2董卫华,马力,赵文君,于捷文,崔秀荣.婴幼儿支原体肺炎的临床特征分析[J].山西医药杂志(上半月),2009,38(11):1042-1043. 被引量:4
  • 3程璐,姜国胜.小儿肺炎支原体肺炎与免疫功能的研究概况[J].中外医学研究,2010,8(10):22-23. 被引量:5
  • 4Ilim T, Boambelli G, Pattarino PL, et al. NK cell cytotoxis activity induced by a synthetic immunostimulant (pidotimod): an in vitro study[J] .J Chemother, 1991,3(3): 157 - 161.
  • 5Capsoni F, Miinonzio F, Ongaria M, et al. In vitro and ex vitro enhancement of neutrophil function by PGT/IA new immunostimulating peptide[J]. J Chemother, 1991,3(3) : 147 - 149.
  • 6Pugliese A, Blglino A, Uslenghi C, et al. Evaluation of pidotimod effect on the immune system[J]. Int J hnmnnotherapy, 1992,8(40): 212 - 217.
  • 7Merom PL, Borghi MO, Barcfuim W, et al. In vitro and in vivo effect of the compound PGT/ 1A on human lymphocytes [ J ]. J Chemother, 1991,3 (3) : 150 - 154.
  • 8Motta G, Campora ED, Vita CD, et ah Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood [J]. Arzneimittelforsch, 1994, 44(12A) :1 521 - 1 524.
  • 9Burgio GR, Marseglia GL, Severi F, et al. hnmunoaetivation by pidotimod in children with recuxTent respiratory infections[J]. Arzneimittelforsch, 1994,44(12A) :1 525 - 1 529.
  • 10黄铁英,叶青.匹多莫德治疗儿童反复呼吸道感染40例[J].中国药业,2009,18(17):73-74. 被引量:2

二级参考文献16

  • 1刁锡东,谢景山,尚少华,周冬,蒋玉红.支原体肺炎病儿红细胞免疫功能动态监测[J].齐鲁医学杂志,1998,13(3):201-201. 被引量:2
  • 2胡仪吉.反复呼吸道感染的诊断标准[J].中华儿科杂志,1988,26(1):41-41.
  • 3Llim T, Boambelli G, Pattarino PL, et al. NK Cell cytotoxis avtivity induced by a synthetic immunostimulant(Pidotimod): an in vitro study[J]. J Chemother, 1991, 3(3): 157 - 161.
  • 4Capsoni F, Miinouzio F, Ongaria M, et al. In vitro and a vivo enhancement of neutrophll function by PGT/1A new immunostimulating Peptid [J]. J Chemother, 1991, 3(3): 147 - 149.
  • 5Pugliese A, Blglino A, Uslenghi C, et al. Evaluation of Pidotimod effect on the immune system[J]. Int Immunotherapy, 1992,8(40): 212-217.
  • 6Merom PL, Borghi Mo, Bracfuim W, et al. In vitro and in vivo offect of the compound PGT/1A on human Lymphocytes[J]. J Chemother, 1991, 3(3): 150- 154.
  • 7Hassan J,Irwin F,Dooley S,et al.Mycoplasma pneumoniae infection in a pediatric population:analysis of soluble immune markers as risk factors for asthma.Hum Immunol,2008,69(12):851-855.
  • 8Shimizu T,Kida Y,Kuwano K.Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2.Immunology,2007,121(4):473-483.
  • 9Stelmach I,Podsiadlowicz Borzecka M,Grzelewski T,et al.Humoral and cellular immunity in children with Mycoplasma pneumoniae infection:a 12 year prospective study.Clin Diagn Lab Immunol,2005,12(10):1246-1250.
  • 10何克茜,周碧艳.反复呼吸道感染与肺炎支原体感染对患儿体液免疫功能的影响[J].中国免疫学杂志,2008,24(5):465-466. 被引量:13

共引文献11

同被引文献50

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部